Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
John Wiley & Sons's Sloan Ratio for the quarter that ended in Apr. 2026 was -2.55%.
As of Apr. 2026, John Wiley & Sons has a Sloan Ratio of -2.55%, indicating the company is in the safe zone and there is no funny business with accruals.
John Wiley & Sons (FRA:2F7) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Apr. 2026, John Wiley & Sons has a Sloan Ratio of -2.55%, indicating the company is in the safe zone and there is no funny business with accruals.
John Wiley & Sons Sloan Ratio % Related Terms
John Wiley & Sons Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for John Wiley & Sons's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2F7 vs TDAY, SCHL, LEE: Sloan Ratio % Comparison
For the Publishing subindustry, John Wiley & Sons's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
John Wiley & Sons Sloan Ratio % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, John Wiley & Sons's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where John Wiley & Sons's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
John Wiley & Sons's Sloan Ratio for the fiscal year that ended in Apr. 2026 is calculated as
John Wiley & Sons's Net Income for the trailing twelve months (TTM) ended in Apr. 2026 was 10.027 (Jul. 2025 ) + 38.561 (Oct. 2025 ) + 25.257 (Jan. 2026 ) + 115.722 (Apr. 2026 ) = €190 Mil.
John Wiley & Sons's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was -72.849 (Jul. 2025 ) + 7.301 (Oct. 2025 ) + 153.024 (Jan. 2026 ) + 134.412 (Apr. 2026 ) = €222 Mil.
John Wiley & Sons's Cash Flow from Investing for the trailing twelve months (TTM) ended in Apr. 2026 was 84.72 (Jul. 2025 ) + -22.693 (Oct. 2025 ) + -22.834 (Jan. 2026 ) + -14.963 (Apr. 2026 ) = €24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
John Wiley & Sons (FRA:2F7) has a Sloan Ratio % of -2.55% as of Apr. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on John Wiley & Sons and its competitors.
Is John Wiley & Sons' Sloan Ratio % too high?
John Wiley & Sons' current Sloan Ratio % is -2.55%. Overall, John Wiley & Sons has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does John Wiley & Sons' Sloan Ratio % compare to TDAY and SCHL?
John Wiley & Sons' Sloan Ratio % of -2.55% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Media - Diversified company?
A good Sloan Ratio % depends on the Media - Diversified industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on John Wiley & Sons and its competitors. John Wiley & Sons's current Sloan Ratio % is -2.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Wiley & Sons stock overvalued right now?
John Wiley & Sons (FRA:2F7) has a current Sloan Ratio % of -2.55%. The stock's GF Value™ is €33.36, compared to a current price of €47.00 — trading 40.9% above its estimated fair value. The current Sloan Ratio % is -2.55%. John Wiley & Sons' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For John Wiley & Sons (FRA:2F7), the current Sloan Ratio % is -2.55% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is John Wiley & Sons (FRA:2F7) Overvalued in 2026?
Based on GuruFocus' analysis, John Wiley & Sons stock appears to be overvalued.
The current stock price of €47.00 is trading 40.9% above its estimated GF Value™ of €33.36.
Key valuation signals for FRA:2F7:
Sloan Ratio %: -2.55%
GF Value™: €33.36 vs. price of €47.00 (40.9% above fair value)
No single metric tells the full story. See the FRA:2F7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
55GF Score
Get the complete analysis for FRA:2F7
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2F7 has been successfully added to your 
